Stephanie Hutchinson
Family · Barbourville, KYNPI 1154640357
Payments from drug & device makers
Across 442 payments — averaging $13.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$813
- Lilly USA, LLC$643
- Novo Nordisk$604
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$380
- Astellas Pharma US Inc$265
- Pfizer$258
- plus $3K from 35 others
What the payments were for
- Food & beverage$5,69596%
- Education$2134%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,908 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $54,697 |
| EliquisApixaban | 28 | $18,523 |
| EntrestoSacubitril/Valsartan | 17 | $16,001 |
| JardianceEmpagliflozin | 13 | $12,868 |
| XareltoRivaroxaban | 11 | $9,444 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,251 |
| Levothyroxine Sodium | 142 | $1,508 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $1,274 |
| Atorvastatin Calcium | 208 | $1,229 |
| Ranolazine ErRanolazine | 12 | $1,029 |
| VascepaIcosapent Ethyl | 11 | $1,000 |
| Duloxetine Hcl | 12 | $917 |
| Omeprazole | 92 | $859 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $677 |
| Amitriptyline Hcl | 52 | $646 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $604 | $54,69750 claims |
| PfizerEliquis | $258 | $18,52328 claims |
| NovartisEntresto | $219 | $16,00117 claims |
| Boehringer IngelheimJardiance | $67 | $12,86813 claims |
| Johnson & JohnsonXarelto | $17 | $9,44411 claims |
| AstraZenecaSymbicort | $121 | $3,25113 claims |
| Lilly USA, LLCOlanzapine | $643 | $45212 claims |
| AbbVieSynthroid | $252 | $27718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in Barbourville
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.